Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab

Toshinori Toyota, Satoshi Narahara, Haruki Uojima, Yuki Kitano, Takahiro Mizuta, Daiki Maeda, Soutarou Kurano, Kentaro Tanaka, Hiroki Inada, Munenori Honda, Yoko Yoshimaru, Takehisa Watanabe, Katsuya Nagaoka, Hiroko Setoyama, Hiromitsu Hayashi, Takanori Suzuki, Kentaro Matsuura, Shuichiro Iwasaki, Nao Nomura, Shiho Miyase, Hideto Yuruki, Yoshinari Sakai, Koichi Kudo, Hisashi Hidaka, Masaaki Iwatsuki, Yasuhito Tanaka

Open source

DOI
10.1111/hepr.70232
Published
2026-07-06
Container
Hepatology Research
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/hepr.70232,
  title = {Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab},
  author = {Toshinori Toyota and Satoshi Narahara and Haruki Uojima and Yuki Kitano and Takahiro Mizuta and Daiki Maeda and Soutarou Kurano and Kentaro Tanaka and Hiroki Inada and Munenori Honda and Yoko Yoshimaru and Takehisa Watanabe and Katsuya Nagaoka and Hiroko Setoyama and Hiromitsu Hayashi and Takanori Suzuki and Kentaro Matsuura and Shuichiro Iwasaki and Nao Nomura and Shiho Miyase and Hideto Yuruki and Yoshinari Sakai and Koichi Kudo and Hisashi Hidaka and Masaaki Iwatsuki and Yasuhito Tanaka},
  year = {2026},
  journal = {Hepatology Research},
  doi = {10.1111/hepr.70232},
  url = {https://doi.org/10.1111/hepr.70232}
}

RIS

TY  - JOUR
TI  - Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab
AU  - Toshinori Toyota
AU  - Satoshi Narahara
AU  - Haruki Uojima
AU  - Yuki Kitano
AU  - Takahiro Mizuta
AU  - Daiki Maeda
AU  - Soutarou Kurano
AU  - Kentaro Tanaka
AU  - Hiroki Inada
AU  - Munenori Honda
AU  - Yoko Yoshimaru
AU  - Takehisa Watanabe
AU  - Katsuya Nagaoka
AU  - Hiroko Setoyama
AU  - Hiromitsu Hayashi
AU  - Takanori Suzuki
AU  - Kentaro Matsuura
AU  - Shuichiro Iwasaki
AU  - Nao Nomura
AU  - Shiho Miyase
AU  - Hideto Yuruki
AU  - Yoshinari Sakai
AU  - Koichi Kudo
AU  - Hisashi Hidaka
AU  - Masaaki Iwatsuki
AU  - Yasuhito Tanaka
PY  - 2026
JO  - Hepatology Research
DO  - 10.1111/hepr.70232
UR  - https://doi.org/10.1111/hepr.70232
ER  - 

APA

Toyota, T., Narahara, S., Uojima, H., Kitano, Y., Mizuta, T., Maeda, D., Kurano, S., Tanaka, K., Inada, H., Honda, M., Yoshimaru, Y., Watanabe, T., Nagaoka, K., Setoyama, H., Hayashi, H., Suzuki, T., Matsuura, K., Iwasaki, S., Nomura, N., Miyase, S., Yuruki, H., Sakai, Y., Kudo, K., Hidaka, H., Iwatsuki, M., & Tanaka, Y. (2026). Statin Use Is Associated With Improved Survival But Not Progression‐Free Outcomes in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab–Bevacizumab. Hepatology Research. https://doi.org/10.1111/hepr.70232

Source records